Kamada (KMDA) Non-Current Debt (2015 - 2025)
Kamada (KMDA) posted quarterly Non-Current Debt of $2.1 million for Q1 2025, down 80.81% on a QoQ basis from $10.7 million in Q2 2023.
Kamada (KMDA) Non-Current Debt (2015 - 2025) Analysis & Trends
Kamada (KMDA) has reported Non-Current Debt for 10 consecutive years, with $2.1 million the latest figure, recorded in Q1 2025.
- Quarterly Non-Current Debt changed N/A year-over-year to $2.1 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $2.1 million (changed N/A YoY) and the FY2022 annual result came in at $13.0 million, down 25.53% from the prior year.
- Non-Current Debt declined to $2.1 million in Q1 2025 per KMDA's latest filing, from $10.7 million in the prior quarter.
- Over the last five years, Non-Current Debt for KMDA reached as high as $17.4 million in Q4 2021 and fell as low as $5000.0 in Q2 2021.
- A 4-year average of $7.5 million and a median of $6.4 million in 2023 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2022 — Non-Current Debt soared 303600.0% — and 2023, when it plunged 99.93%.
- Year by year, Non-Current Debt stood at $17.4 million in 2021, then retreated by 25.53% to $13.0 million in 2022, then retreated by 17.14% to $10.7 million in 2023, then sank by 80.81% to $2.1 million in 2025.
- According to Business Quant data, Non-Current Debt over the past three periods registered $2.1 million, $10.7 million, and $11852.0 for Q1 2025, Q2 2023, and Q1 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 10.34 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 14.02 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 27.86 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 12.41 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.74 Bn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 2.06 Mn |
| Jun 30, 2023 | 10.74 Mn |
| Mar 31, 2023 | 11,852.00 |
| Dec 31, 2022 | 12.96 Mn |
| Sep 30, 2022 | 14,074.00 |
| Jun 30, 2022 | 15.19 Mn |
| Mar 31, 2022 | 16.30 Mn |
| Dec 31, 2021 | 17.41 Mn |
| Jun 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 20,000.00 |
| Dec 31, 2020 | 36,000.00 |
| Sep 30, 2020 | 48,000.00 |
| Jun 30, 2020 | 63,000.00 |
| Mar 31, 2020 | 138,000.00 |
| Dec 31, 2019 | 257,000.00 |
| Sep 30, 2019 | 461,000.00 |
| Jun 30, 2019 | 482,000.00 |
| Mar 31, 2019 | 591,000.00 |
| Dec 31, 2018 | 688,000.00 |
| Dec 31, 2017 | 1.37 Mn |